Camilla Zuckero

VP, Investor Relations & Corporate Affairs at Castle Biosciences

Camilla Zuckero has served as our Vice President, Investor Relations & Corporate Affairs, since January 2022. Ms. Zuckero joined Castle in October 2019 as our Executive Director, Investor Relations & Corporate Communications. In her current role, Ms. Zuckero leads the development and execution of Castle’s investor relations and corporate affairs strategy, including the company’s environmental, social and governance (ESG), corporate communications, public relations and patient advocacy programs. Before joining Castle, Ms. Zuckero was responsible for the investor relations and external communications functions at Sysco Corporation, the world’s largest foodservice distributor. Prior to Sysco, she led investor relations and communications for Opexa Therapeutics, a publicly traded biotechnology company developing novel T-cell therapies for the treatment of autoimmune disorders.

Ms. Zuckero is a member of Women in Bio, International Association of Business Communicators, Latin Women’s Initiative and the National Investor Relations Institute, and holds a M.S. degree in marketing and communication.

Links